Transitory dasatinib-resistant states in KITmut t(8;21) acute myeloid leukemia cells correlate with altered KIT expression

Markus D. Herrmann(University Hospital Ulm), Klaus‐Michael Debatin(University Hospital Ulm)

Experimental Hematology

November 6, 2013

10.1016/j.exphem.2013.10.006

Cited by 12

Related Papers

Newly identified c-KIT receptor tyrosine kinase ITD in childhood AML induces ligand-independent growth and is responsive to a synergistic effect of imatinib and rapamycin

|Blood|2006|72

CD95 co-stimulation blocks activation of naive T cells by inhibiting T cell receptor signaling

|The Journal of Experimental Medicine|2009|47

Remission induction in refractory, drug resistant pediatric PICALM::MLLT10+ B-cell acute lymphoblastic leukemia by venetoclax

|Leukemia|2025|4